Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Sint-Truiden – page 22

1 831 clinical trials in Sint-Truiden, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Sint-Truiden at a glance
1 831
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

1 831 trials in Sint-Truiden

Open in trial search

A study testing the safety and effects of ADS-019 in adults aged 18 to 65 years with type 1 myotonic dystrophy

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:ADS-019
  • Sponsor:Sarepta Therapeutics Inc.

Study of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Glepaglutide
  • Sponsor:Zealand Pharma A/S

Breast cancer+1

Recruiting

Study of inavolisib and fulvestrant for patients with PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Fulvestrant
  • Sponsor:F. Hoffmann-La Roche AG

A study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bleximenib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Endometrial cancer+3

Recruiting

Study of ubamatamab alone or with cemiplimab for adults with ovarian, fallopian tube, peritoneal, or endometrial cancer that has come back

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Regeneron Pharmaceuticals Inc.

Study of oral cladribine compared to placebo for patients with generalized myasthenia gravis

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cladribine
  • Sponsor:Merck Healthcare KGaA

Hyperkalaemia

Recruiting

A study testing how well patiromer lowers high potassium levels in the blood in children under 12 years of age with hyperkalemia

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Patiromer
  • Sponsor:Vifor Pharma Inc.

A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Regeneron Pharmaceuticals Inc.

Endocarditis

Recruiting

Study of Switching from Intravenous to Oral Antibiotics in Patients with Infective Endocarditis Using a Drug Combination

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:UZ Leuven

Comparing Two Doses of Dexamethasone to Improve Quality of Life in Patients 60 Years and Older Having Total Hip Replacement Surgery

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone Sodium Phosphate
  • Sponsor:Ziekenhuis Oost Limburg

A Study Using [AL[18F]F]FAPI-74 PET Scan to Improve Diagnosis and Monitoring of Giant Cell Arteritis in Patients with This Blood Vessel Disease

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:[Al[18F]F]Fapi-74
  • Sponsor:UZ Leuven

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Sint-Truiden

What the registry says about research in the country

01 Oncology Research

Groundbreaking clinical trials focusing on colon cancer treatment and survival outcomes. The research explores innovative approaches to prevent cancer recurrence in patients who have undergone surgical treatment.

  • Cancer Recurrence Prevention
  • Post-Surgery Treatment
  • Long-term Survival Studies

This research investigates the potential benefits of common acetylsalicylic acid in improving survival rates for patients with stage II and III colon cancer, representing a significant advancement in post-operative cancer care protocols.

02 Preventive Medicine

Innovative research examining the role of daily preventive therapy in cancer management. The study focuses on long-term treatment strategies spanning five years to enhance patient outcomes.

  • Preventive Therapeutics
  • Extended Care Protocols
  • Patient Monitoring

This comprehensive trial evaluates the effectiveness of low-dose medication regimens in preventing cancer recurrence, potentially establishing new standards in preventive oncology.

03 Surgical Oncology

Advanced research targeting patients with resected colon carcinoma, exploring post-surgical intervention strategies to improve long-term patient outcomes.

  • Post-Surgical Care
  • Recovery Monitoring
  • Treatment Optimization

The study aims to establish effective post-surgical treatment protocols, potentially transforming the standard of care for colon cancer patients following tumor resection.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.